WWL229
WWL229 is a selective inhibitor of carboxylesterase 3 (Ces3) with an IC50 of 1.94 µM. WWL229 promotes lipid storage in cultured adipocytes and prevents basal lipolysis[1].
Product Specifications
CAS Number
1338575-28-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Carboxylesterase (CES)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/wwl229.html
Purity
99.49
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(N1CCCCC1CCCOC)OC2=CC=C(C=C2)[N+]([O-])=O
Molecular Formula
C16H22N2O5
Molecular Weight
322.36
Precautions
H302, H315, H319
References & Citations
[1]Dominguez E, et al. Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes. Nat Chem Biol. 2014 Feb;10 (2) :113-21.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CES3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF405S conjugate, 0.1mg/mL
